APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Pathology Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digital Pathology Software Market Analysis and Forecast 2026-2032

12 August 2026198 pages

Choose your research edition.

Industry ResearchDigital Pathology Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Pathology Software Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Digital Pathology Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Pathology Software Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Pathology Software Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Digital Pathology Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digital Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digital Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digital Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digital Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digital Pathology Software include Roche, 3DHISTECH, Hamamatsu Photonics, ZEISS, OptraScan, Media Cyber​​netics, Visiopharm, Sectra and Digital Slide Archive, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digital Pathology Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digital Pathology Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital Pathology Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital Pathology Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital Pathology Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital Pathology Software revenue, projected growth trends, production technology, application and end-user industry.

Digital Pathology Software Segment by Company

Roche

3DHISTECH

Hamamatsu Photonics

ZEISS

OptraScan

Media Cyber​​netics

Visiopharm

Sectra

Digital Slide Archive

Aiforia

PathAI

Pathomation

Proscia

Indica Labs

Gestalt

Xybion

NovoPath

Glencoe Software

Orbit Image Analysis

Augmentiqs

Leica Biosystems

Olympus

Philips

Digital Pathology Software Segment by Type

Open-Source Platforms

Closed-Source Platforms

Digital Pathology Software Segment by Application

Pharmaceutical

Clinical Use

Research

Education

Digital Pathology Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pathology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Pathology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pathology Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digital Pathology Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digital Pathology Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Pathology Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital Pathology Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Open-Source Platforms Major Player Table 3. Closed-Source Platforms Major Player Table 4. Global Digital Pathology Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Major Player Table 6. Clinical Use Major Player Table 7. Research Major Player Table 8. Education Major Player Table 9. Digital Pathology Software Industry Trends Table 10. Digital Pathology Software Industry Drivers Table 11. Digital Pathology Software Industry Opportunities and Challenges Table 12. Digital Pathology Software Industry Restraints Table 13. Global Digital Pathology Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Digital Pathology Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Digital Pathology Software Market Share by Region (2021-2026) Table 16. Global Digital Pathology Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Digital Pathology Software Market Share by Region (2027-2032) Table 18. Global Digital Pathology Software Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Digital Pathology Software Revenue Market Share by Players (2021-2026) Table 20. Global Digital Pathology Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Digital Pathology Software Key Players Headquarters & Area Served Table 22. Global Digital Pathology Software Players, Product Type & Application Table 23. Global Digital Pathology Software Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Digital Pathology Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Digital Pathology Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Digital Pathology Software Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Digital Pathology Software Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Digital Pathology Software Revenue Market Share by Type (2021-2026) Table 30. Global Digital Pathology Software Revenue Market Share by Type (2027-2032) Table 31. Global Digital Pathology Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Digital Pathology Software Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Digital Pathology Software Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Digital Pathology Software Revenue Market Share by Application (2021-2026) Table 35. Global Digital Pathology Software Revenue Market Share by Application (2027-2032) Table 36. Roche Company Information Table 37. Roche Business Overview Table 38. Roche Digital Pathology Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Roche Digital Pathology Software Product Portfolio Table 40. Roche Recent Development Table 41. 3DHISTECH Company Information Table 42. 3DHISTECH Business Overview Table 43. 3DHISTECH Digital Pathology Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. 3DHISTECH Digital Pathology Software Product Portfolio Table 45. 3DHISTECH Recent Development Table 46. Hamamatsu Photonics Company Information Table 47. Hamamatsu Photonics Business Overview Table 48. Hamamatsu Photonics Digital Pathology Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Hamamatsu Photonics Digital Pathology Software Product Portfolio Table 50. Hamamatsu Photonics Recent Development Table 51. ZEISS Company Information Table 52. ZEISS Business Overview Table 53. ZEISS Digital Pathology Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. ZEISS Digital Pathology Software Product Portfolio Table 55. ZEISS Recent Development Table 56. OptraScan Company Information Table 57. OptraScan Business Overview Table 58. OptraScan Digital Pathology Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. OptraScan Digital Pathology Software Product Portfolio Table 60. OptraScan Recent Development Table 61. Media Cyber​​netics Company Information Table 62. Media Cyber​​netics Business Overview Table 63. Media Cyber​​netics Digital Pathology Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Media Cyber​​netics Digital Pathology Software Product Portfolio Table 65. Media Cyber​​netics Recent Development Table 66. Visiopharm Company Information Table 67. Visiopharm Business Overview Table 68. Visiopharm Digital Pathology Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Visiopharm Digital Pathology Software Product Portfolio Table 70. Visiopharm Recent Development Table 71. Sectra Company Information Table 72. Sectra Business Overview Table 73. Sectra Digital Pathology Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Sectra Digital Pathology Software Product Portfolio Table 75. Sectra Recent Development Table 76. Digital Slide Archive Company Information Table 77. Digital Slide Archive Business Overview Table 78. Digital Slide Archive Digital Pathology Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Digital Slide Archive Digital Pathology Software Product Portfolio Table 80. Digital Slide Archive Recent Development Table 81. Aiforia Company Information Table 82. Aiforia Business Overview Table 83. Aiforia Digital Pathology Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Aiforia Digital Pathology Software Product Portfolio Table 85. Aiforia Recent Development Table 86. PathAI Company Information Table 87. PathAI Business Overview Table 88. PathAI Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. PathAI Digital Pathology Software Product Portfolio Table 90. PathAI Recent Development Table 91. Pathomation Company Information Table 92. Pathomation Business Overview Table 93. Pathomation Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Pathomation Digital Pathology Software Product Portfolio Table 95. Pathomation Recent Development Table 96. Proscia Company Information Table 97. Proscia Business Overview Table 98. Proscia Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Proscia Digital Pathology Software Product Portfolio Table 100. Proscia Recent Development Table 101. Indica Labs Company Information Table 102. Indica Labs Business Overview Table 103. Indica Labs Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Indica Labs Digital Pathology Software Product Portfolio Table 105. Indica Labs Recent Development Table 106. Gestalt Company Information Table 107. Gestalt Business Overview Table 108. Gestalt Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Gestalt Digital Pathology Software Product Portfolio Table 110. Gestalt Recent Development Table 111. Xybion Company Information Table 112. Xybion Business Overview Table 113. Xybion Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Xybion Digital Pathology Software Product Portfolio Table 115. Xybion Recent Development Table 116. NovoPath Company Information Table 117. NovoPath Business Overview Table 118. NovoPath Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. NovoPath Digital Pathology Software Product Portfolio Table 120. NovoPath Recent Development Table 121. Glencoe Software Company Information Table 122. Glencoe Software Business Overview Table 123. Glencoe Software Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Glencoe Software Digital Pathology Software Product Portfolio Table 125. Glencoe Software Recent Development Table 126. Orbit Image Analysis Company Information Table 127. Orbit Image Analysis Business Overview Table 128. Orbit Image Analysis Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Orbit Image Analysis Digital Pathology Software Product Portfolio Table 130. Orbit Image Analysis Recent Development Table 131. Augmentiqs Company Information Table 132. Augmentiqs Business Overview Table 133. Augmentiqs Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Augmentiqs Digital Pathology Software Product Portfolio Table 135. Augmentiqs Recent Development Table 136. Leica Biosystems Company Information Table 137. Leica Biosystems Business Overview Table 138. Leica Biosystems Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Leica Biosystems Digital Pathology Software Product Portfolio Table 140. Leica Biosystems Recent Development Table 141. Olympus Company Information Table 142. Olympus Business Overview Table 143. Olympus Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Olympus Digital Pathology Software Product Portfolio Table 145. Olympus Recent Development Table 146. Philips Company Information Table 147. Philips Business Overview Table 148. Philips Digital Pathology Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Philips Digital Pathology Software Product Portfolio Table 150. Philips Recent Development Table 151. North America Digital Pathology Software Revenue by Type (2021-2026) & (US$ Million) Table 152. North America Digital Pathology Software Revenue by Type (2027-2032) & (US$ Million) Table 153. North America Digital Pathology Software Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Digital Pathology Software Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Digital Pathology Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. North America Digital Pathology Software Revenue by Country (2021-2026) & (US$ Million) Table 157. North America Digital Pathology Software Revenue by Country (US$ Million) & (2027-2032) Table 158. Europe Digital Pathology Software Revenue by Type (2021-2026) & (US$ Million) Table 159. Europe Digital Pathology Software Revenue by Type (2027-2032) & (US$ Million) Table 160. Europe Digital Pathology Software Revenue by Application (2021-2026) & (US$ Million) Table 161. Europe Digital Pathology Software Revenue by Application (2027-2032) & (US$ Million) Table 162. Europe Digital Pathology Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Europe Digital Pathology Software Revenue by Country (2021-2026) & (US$ Million) Table 164. Europe Digital Pathology Software Revenue by Country (US$ Million) & (2027-2032) Table 165. China Digital Pathology Software Revenue by Type (2021-2026) & (US$ Million) Table 166. China Digital Pathology Software Revenue by Type (2027-2032) & (US$ Million) Table 167. China Digital Pathology Software Revenue by Application (2021-2026) & (US$ Million) Table 168. China Digital Pathology Software Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Digital Pathology Software Revenue by Type (2021-2026) & (US$ Million) Table 170. Asia Digital Pathology Software Revenue by Type (2027-2032) & (US$ Million) Table 171. Asia Digital Pathology Software Revenue by Application (2021-2026) & (US$ Million) Table 172. Asia Digital Pathology Software Revenue by Application (2027-2032) & (US$ Million) Table 173. Asia Digital Pathology Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Digital Pathology Software Revenue by Region (US$ Million) & (2021-2026) Table 175. Asia Digital Pathology Software Revenue by Region (US$ Million) & (2027-2032) Table 176. SAMEA Digital Pathology Software Revenue by Type (2021-2026) & (US$ Million) Table 177. SAMEA Digital Pathology Software Revenue by Type (2027-2032) & (US$ Million) Table 178. SAMEA Digital Pathology Software Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Digital Pathology Software Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Digital Pathology Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Digital Pathology Software Revenue by Country (2021-2026) & (US$ Million) Table 182. SAMEA Digital Pathology Software Revenue by Country (US$ Million) & (2027-2032) Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Digital Pathology Software Image Figure 2. Global Digital Pathology Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Pathology Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Open-Source Platforms Image Figure 5. Closed-Source Platforms Image Figure 6. Global Digital Pathology Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Digital Pathology Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical Image Figure 9. Clinical Use Image Figure 10. Research Image Figure 11. Education Image Figure 12. Global Digital Pathology Software Market Size (US$ Million) & (2021-2032) Figure 13. Global Digital Pathology Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Digital Pathology Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Digital Pathology Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Digital Pathology Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Digital Pathology Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Digital Pathology Software Revenue Market Share by Type (2021-2032) Figure 20. Global Digital Pathology Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Digital Pathology Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Digital Pathology Software Revenue Market Share by Application (2021-2032) Figure 23. North America Digital Pathology Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Digital Pathology Software Revenue Share by Type (2021-2032) Figure 25. North America Digital Pathology Software Revenue Share by Application (2021-2032) Figure 26. North America Digital Pathology Software Revenue Share by Country (2021-2032) Figure 27. United States Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Digital Pathology Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Digital Pathology Software Revenue Share by Type (2021-2032) Figure 32. Europe Digital Pathology Software Revenue Share by Application (2021-2032) Figure 33. Europe Digital Pathology Software Revenue Share by Country (2021-2032) Figure 34. Germany Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Digital Pathology Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Digital Pathology Software Revenue Share by Type (2021-2032) Figure 44. China Digital Pathology Software Revenue Share by Application (2021-2032) Figure 45. Asia Digital Pathology Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Digital Pathology Software Revenue Share by Type (2021-2032) Figure 47. Asia Digital Pathology Software Revenue Share by Application (2021-2032) Figure 48. Asia Digital Pathology Software Revenue Share by Region (2021-2032) Figure 49. Japan Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Digital Pathology Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Digital Pathology Software Revenue Share by Type (2021-2032) Figure 57. SAMEA Digital Pathology Software Revenue Share by Application (2021-2032) Figure 58. SAMEA Digital Pathology Software Revenue Share by Country (2021-2032) Figure 59. Brazil Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Digital Pathology Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Open-Source Platforms
  • Closed-Source Platforms
Applications
  • Pharmaceutical
  • Clinical Use
  • Research
  • Education
Companies covered
  • Roche
  • 3DHISTECH
  • Hamamatsu Photonics
  • ZEISS
  • OptraScan
  • Media Cyber​​netics
  • Visiopharm
  • Sectra
  • Digital Slide Archive
  • Aiforia
  • PathAI
  • Pathomation
  • Proscia
  • Indica Labs
  • Gestalt
  • Xybion
  • NovoPath
  • Glencoe Software
  • Orbit Image Analysis
  • Augmentiqs
  • Leica Biosystems
  • Olympus
  • Philips

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digital Pathology Software Market by Type
  3. 1.2.1 Global Digital Pathology Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Open-Source Platforms
  5. 1.2.3 Closed-Source Platforms
  6. 1.3 Digital Pathology Software Market by Application
  7. 1.3.1 Global Digital Pathology Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical
  9. 1.3.3 Clinical Use
  10. 1.3.4 Research
  11. 1.3.5 Education
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Digital Pathology Software Market Dynamics
  1. 2.1 Digital Pathology Software Industry Trends
  2. 2.2 Digital Pathology Software Industry Drivers
  3. 2.3 Digital Pathology Software Industry Opportunities and Challenges
  4. 2.4 Digital Pathology Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digital Pathology Software Market Perspective (2021-2032)
  2. 3.2 Global Digital Pathology Software Growth Trends by Region
  3. 3.2.1 Global Digital Pathology Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digital Pathology Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Digital Pathology Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digital Pathology Software Revenue by Players
  2. 4.1.1 Global Digital Pathology Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Digital Pathology Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digital Pathology Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digital Pathology Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digital Pathology Software Key Players Headquarters & Area Served
  7. 4.4 Global Digital Pathology Software Players, Product Type & Application
  8. 4.5 Global Digital Pathology Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digital Pathology Software Market CR5 and HHI
  11. 4.6.3 2025 Digital Pathology Software Tier 1, Tier 2, and Tier 3
5 Digital Pathology Software Market Size by Type
  1. 5.1 Global Digital Pathology Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital Pathology Software Revenue by Type (2021-2032)
  3. 5.3 Global Digital Pathology Software Revenue Market Share by Type (2021-2032)
6 Digital Pathology Software Market Size by Application
  1. 6.1 Global Digital Pathology Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digital Pathology Software Revenue by Application (2021-2032)
  3. 6.3 Global Digital Pathology Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Digital Pathology Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Roche Digital Pathology Software Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 3DHISTECH
  8. 7.2.1 3DHISTECH Company Information
  9. 7.2.2 3DHISTECH Business Overview
  10. 7.2.3 3DHISTECH Digital Pathology Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 3DHISTECH Digital Pathology Software Product Portfolio
  12. 7.2.5 3DHISTECH Recent Developments
  13. 7.3 Hamamatsu Photonics
  14. 7.3.1 Hamamatsu Photonics Company Information
  15. 7.3.2 Hamamatsu Photonics Business Overview
  16. 7.3.3 Hamamatsu Photonics Digital Pathology Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Hamamatsu Photonics Digital Pathology Software Product Portfolio
  18. 7.3.5 Hamamatsu Photonics Recent Developments
  19. 7.4 ZEISS
  20. 7.4.1 ZEISS Company Information
  21. 7.4.2 ZEISS Business Overview
  22. 7.4.3 ZEISS Digital Pathology Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ZEISS Digital Pathology Software Product Portfolio
  24. 7.4.5 ZEISS Recent Developments
  25. 7.5 OptraScan
  26. 7.5.1 OptraScan Company Information
  27. 7.5.2 OptraScan Business Overview
  28. 7.5.3 OptraScan Digital Pathology Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 OptraScan Digital Pathology Software Product Portfolio
  30. 7.5.5 OptraScan Recent Developments
  31. 7.6 Media Cyber​​netics
  32. 7.6.1 Media Cyber​​netics Company Information
  33. 7.6.2 Media Cyber​​netics Business Overview
  34. 7.6.3 Media Cyber​​netics Digital Pathology Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Media Cyber​​netics Digital Pathology Software Product Portfolio
  36. 7.6.5 Media Cyber​​netics Recent Developments
  37. 7.7 Visiopharm
  38. 7.7.1 Visiopharm Company Information
  39. 7.7.2 Visiopharm Business Overview
  40. 7.7.3 Visiopharm Digital Pathology Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Visiopharm Digital Pathology Software Product Portfolio
  42. 7.7.5 Visiopharm Recent Developments
  43. 7.8 Sectra
  44. 7.8.1 Sectra Company Information
  45. 7.8.2 Sectra Business Overview
  46. 7.8.3 Sectra Digital Pathology Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sectra Digital Pathology Software Product Portfolio
  48. 7.8.5 Sectra Recent Developments
  49. 7.9 Digital Slide Archive
  50. 7.9.1 Digital Slide Archive Company Information
  51. 7.9.2 Digital Slide Archive Business Overview
  52. 7.9.3 Digital Slide Archive Digital Pathology Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Digital Slide Archive Digital Pathology Software Product Portfolio
  54. 7.9.5 Digital Slide Archive Recent Developments
  55. 7.10 Aiforia
  56. 7.10.1 Aiforia Company Information
  57. 7.10.2 Aiforia Business Overview
  58. 7.10.3 Aiforia Digital Pathology Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Aiforia Digital Pathology Software Product Portfolio
  60. 7.10.5 Aiforia Recent Developments
  61. 7.11 PathAI
  62. 7.11.1 PathAI Company Information
  63. 7.11.2 PathAI Business Overview
  64. 7.11.3 PathAI Digital Pathology Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 PathAI Digital Pathology Software Product Portfolio
  66. 7.11.5 PathAI Recent Developments
  67. 7.12 Pathomation
  68. 7.12.1 Pathomation Company Information
  69. 7.12.2 Pathomation Business Overview
  70. 7.12.3 Pathomation Digital Pathology Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Pathomation Digital Pathology Software Product Portfolio
  72. 7.12.5 Pathomation Recent Developments
  73. 7.13 Proscia
  74. 7.13.1 Proscia Company Information
  75. 7.13.2 Proscia Business Overview
  76. 7.13.3 Proscia Digital Pathology Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Proscia Digital Pathology Software Product Portfolio
  78. 7.13.5 Proscia Recent Developments
  79. 7.14 Indica Labs
  80. 7.14.1 Indica Labs Company Information
  81. 7.14.2 Indica Labs Business Overview
  82. 7.14.3 Indica Labs Digital Pathology Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Indica Labs Digital Pathology Software Product Portfolio
  84. 7.14.5 Indica Labs Recent Developments
  85. 7.15 Gestalt
  86. 7.15.1 Gestalt Company Information
  87. 7.15.2 Gestalt Business Overview
  88. 7.15.3 Gestalt Digital Pathology Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Gestalt Digital Pathology Software Product Portfolio
  90. 7.15.5 Gestalt Recent Developments
  91. 7.16 Xybion
  92. 7.16.1 Xybion Company Information
  93. 7.16.2 Xybion Business Overview
  94. 7.16.3 Xybion Digital Pathology Software Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Xybion Digital Pathology Software Product Portfolio
  96. 7.16.5 Xybion Recent Developments
  97. 7.17 NovoPath
  98. 7.17.1 NovoPath Company Information
  99. 7.17.2 NovoPath Business Overview
  100. 7.17.3 NovoPath Digital Pathology Software Revenue and Gross Margin (2021-2026)
  101. 7.17.4 NovoPath Digital Pathology Software Product Portfolio
  102. 7.17.5 NovoPath Recent Developments
  103. 7.18 Glencoe Software
  104. 7.18.1 Glencoe Software Company Information
  105. 7.18.2 Glencoe Software Business Overview
  106. 7.18.3 Glencoe Software Digital Pathology Software Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Glencoe Software Digital Pathology Software Product Portfolio
  108. 7.18.5 Glencoe Software Recent Developments
  109. 7.19 Orbit Image Analysis
  110. 7.19.1 Orbit Image Analysis Company Information
  111. 7.19.2 Orbit Image Analysis Business Overview
  112. 7.19.3 Orbit Image Analysis Digital Pathology Software Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Orbit Image Analysis Digital Pathology Software Product Portfolio
  114. 7.19.5 Orbit Image Analysis Recent Developments
  115. 7.20 Augmentiqs
  116. 7.20.1 Augmentiqs Company Information
  117. 7.20.2 Augmentiqs Business Overview
  118. 7.20.3 Augmentiqs Digital Pathology Software Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Augmentiqs Digital Pathology Software Product Portfolio
  120. 7.20.5 Augmentiqs Recent Developments
  121. 7.21 Leica Biosystems
  122. 7.21.1 Leica Biosystems Company Information
  123. 7.21.2 Leica Biosystems Business Overview
  124. 7.21.3 Leica Biosystems Digital Pathology Software Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Leica Biosystems Digital Pathology Software Product Portfolio
  126. 7.21.5 Leica Biosystems Recent Developments
  127. 7.22 Olympus
  128. 7.22.1 Olympus Company Information
  129. 7.22.2 Olympus Business Overview
  130. 7.22.3 Olympus Digital Pathology Software Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Olympus Digital Pathology Software Product Portfolio
  132. 7.22.5 Olympus Recent Developments
  133. 7.23 Philips
  134. 7.23.1 Philips Company Information
  135. 7.23.2 Philips Business Overview
  136. 7.23.3 Philips Digital Pathology Software Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Philips Digital Pathology Software Product Portfolio
  138. 7.23.5 Philips Recent Developments
8 North America
  1. 8.1 North America Digital Pathology Software Revenue (2021-2032)
  2. 8.2 North America Digital Pathology Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Digital Pathology Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Digital Pathology Software Revenue by Type (2027-2032)
  5. 8.3 North America Digital Pathology Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Digital Pathology Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Digital Pathology Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Digital Pathology Software Revenue by Application (2027-2032)
  9. 8.5 North America Digital Pathology Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Digital Pathology Software Revenue by Country
  11. 8.6.1 North America Digital Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digital Pathology Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Digital Pathology Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digital Pathology Software Revenue (2021-2032)
  2. 9.2 Europe Digital Pathology Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digital Pathology Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digital Pathology Software Revenue by Type (2027-2032)
  5. 9.3 Europe Digital Pathology Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digital Pathology Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digital Pathology Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digital Pathology Software Revenue by Application (2027-2032)
  9. 9.5 Europe Digital Pathology Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digital Pathology Software Revenue by Country
  11. 9.6.1 Europe Digital Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digital Pathology Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digital Pathology Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digital Pathology Software Revenue (2021-2032)
  2. 10.2 China Digital Pathology Software Revenue by Type (2021-2032)
  3. 10.2.1 China Digital Pathology Software Revenue by Type (2021-2026)
  4. 10.2.2 China Digital Pathology Software Revenue by Type (2027-2032)
  5. 10.3 China Digital Pathology Software Revenue Share by Type (2021-2032)
  6. 10.4 China Digital Pathology Software Revenue by Application (2021-2032)
  7. 10.4.1 China Digital Pathology Software Revenue by Application (2021-2026)
  8. 10.4.2 China Digital Pathology Software Revenue by Application (2027-2032)
  9. 10.5 China Digital Pathology Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digital Pathology Software Revenue (2021-2032)
  2. 11.2 Asia Digital Pathology Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digital Pathology Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digital Pathology Software Revenue by Type (2027-2032)
  5. 11.3 Asia Digital Pathology Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digital Pathology Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digital Pathology Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digital Pathology Software Revenue by Application (2027-2032)
  9. 11.5 Asia Digital Pathology Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digital Pathology Software Revenue by Country
  11. 11.6.1 Asia Digital Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digital Pathology Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digital Pathology Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digital Pathology Software Revenue (2021-2032)
  2. 12.2 SAMEA Digital Pathology Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digital Pathology Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digital Pathology Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digital Pathology Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digital Pathology Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digital Pathology Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digital Pathology Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digital Pathology Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digital Pathology Software Revenue by Country
  11. 12.6.1 SAMEA Digital Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digital Pathology Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digital Pathology Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst